Quick Answer
ATOSSA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $41.30 million for the year ending 2025.
- ATOSSA THERAPEUTICS, INC. showed a decrease of -41.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $899.5 thousand | Q2 2012: $88.0 thousand | Q3 2012: $418.6 thousand | Q1 2013: $1.39 million | Q2 2013: $2.44 million | Q3 2013: $7.69 million | Q1 2014: $16.59 million | Q2 2014: $14.30 million | Q3 2014: $11.37 million | Q1 2015: $9.73 million | Q2 2015: $11.40 million | Q3 2015: $7.84 million | Q1 2016: $2.88 million | Q2 2016: $1.19 million | Q3 2016: $4.39 million | Q1 2017: $1.17 million | Q2 2017: $3.69 million | Q3 2017: $2.73 million | Q1 2018: $4.78 million | Q2 2018: $15.24 million | Q3 2018: $12.94 million | Q1 2019: $19.57 million | Q2 2019: $17.06 million | Q3 2019: $15.29 million | Q1 2020: $9.35 million | Q2 2020: $7.46 million | Q3 2020: $9.11 million | Q1 2021: $137.57 million | Q2 2021: $142.43 million | Q3 2021: $140.04 million | Q1 2022: $131.49 million | Q2 2022: $125.54 million | Q3 2022: $117.37 million | Q1 2023: $103.87 million | Q2 2023: $99.39 million | Q3 2023: $94.03 million | Q1 2024: $83.96 million | Q2 2024: $79.53 million | Q3 2024: $74.77 million | Q1 2025: $65.12 million | Q2 2025: $57.86 million | Q3 2025: $51.85 million.
- Historical annual values: Fiscal year 2025: $41.30 million | Fiscal year 2024: $71.08 million | Fiscal year 2023: $88.46 million | Fiscal year 2022: $110.89 million | Fiscal year 2021: $136.38 million | Fiscal year 2020: $39.55 million | Fiscal year 2019: $12.58 million | Fiscal year 2018: $10.38 million | Fiscal year 2017: $7.22 million | Fiscal year 2016: $3.03 million | Fiscal year 2015: $3.72 million | Fiscal year 2014: $8.50 million | Fiscal year 2013: $6.34 million | Fiscal year 2012: $1.73 million | Fiscal year 2011: $1.91 million | Fiscal year 2010: $10.3 thousand | Fiscal year 2009: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: